Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Higher Regional Court of Hamburg: On the risk classification of health apps
Higher Regional Court of Nuremberg: In principle, no loss of urgency due to the full utilisation of legal deadlines
by multiple authors
by multiple authors
by Julia Siedhoff and Dr. Hendrik Boss
by multiple authors
by multiple authors
by multiple authors
by multiple authors
by Katie Chandler and Samantha Brendish
by Katie Chandler and Samantha Brendish
by multiple authors